Literature DB >> 23608848

Multidrug resistant citrobacter: an unusual cause of liver abscess.

Prabhat Kumar1, Soumik Ghosh, Deepak Rath, A K Gadpayle.   

Abstract

Liver abscesses are infectious, space occupying lesions in the liver, the two most common abscesses being pyogenic and amoebic. A pyogenic liver abscess (PLA) is a rare condition with a reported incidence of 20 per 100 000 hospital admissions in the western population. The right lobe of the liver is the most common site in both types of liver abscess. Clinical presentation is elusive with complaints of fever, right upper quadrant pain in the abdomen and hepatomegaly with or without jaundice. The aetiology of PLA has changed in the past few decades and may be of biliary, portal, arterial or traumatic origin, but many cases are still cryptogenic. The most common organisms causing PLA are Gram-negative aerobes, especially Escherichia coli and Klebsiella pneumoniae. Studies have shown a high degree of antimicrobial susceptibility of isolated organism resulting in an overall lower mortality in PLA. Here, we present a case of PLA caused by multidrug-resistant Citrobacter freundii, which is an unusual organism to be isolated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23608848      PMCID: PMC3645642          DOI: 10.1136/bcr-2013-008714

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Spontaneous Citrobacter freundii infection in an immunocompetent patient.

Authors:  Jason G Whalen; Thaddeus W Mully; Joseph C English
Journal:  Arch Dermatol       Date:  2007-01

2.  [Citrobacter freundii, a rare cause of hepatic abscess].

Authors:  F Laynez Bretones; G López Martínez; F Díez García; M C Gálvez Contreras; A Collado Romacho
Journal:  An Med Interna       Date:  1998-08

Review 3.  Citrobacter meningitis and brain abscess in infancy: epidemiology, pathogenesis, and treatment.

Authors:  M W Kline
Journal:  J Pediatr       Date:  1988-09       Impact factor: 4.406

4.  Ascending cholangitis as a cause of pyogenic liver abscesses complicated by a gastric submucosal abscess and fistula.

Authors:  T Yamada; K Murakami; K Tsuchida; H Ohara; T Nakazawa; H Sano; H Ando; T Hashimoto; T Nomura; Y Yokoyama; M Itoh
Journal:  J Clin Gastroenterol       Date:  2000-04       Impact factor: 3.062

5.  Comparison of antimicrobial susceptibility of Citrobacter freundii isolates in two different time periods.

Authors:  J T Wang; S C Chang; Y C Chen; K T Luh
Journal:  J Microbiol Immunol Infect       Date:  2000-12       Impact factor: 4.399

6.  Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.

Authors:  Peter W Kim; Anthony D Harris; Mary-Claire Roghmann; J Glenn Morris; Arjun Strinivasan; Eli N Perencevich
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

Review 7.  Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature.

Authors:  B A Lipsky; E W Hook; A A Smith; J J Plorde
Journal:  Rev Infect Dis       Date:  1980 Sep-Oct

8.  In vitro susceptibility of Citrobacter species to various antimicrobial agents.

Authors:  G Samonis; D H Ho; G F Gooch; K V Rolston; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

  8 in total
  3 in total

1.  Pyogenic liver abscess after gunshot injury: 10 years' experience at a single level 1 trauma center.

Authors:  O Dandin; E J Valle; G Pimentha; C I Schulman; U Teomete; K G Proctor; N Namias
Journal:  Ir J Med Sci       Date:  2015-09-16       Impact factor: 1.568

2.  The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses.

Authors:  Marcus M Mücke; Johanna Kessel; Victoria T Mücke; Katharina Schwarzkopf; Michael Hogardt; Christoph Stephan; Stefan Zeuzem; Volkhard A J Kempf; Christian M Lange
Journal:  BMC Infect Dis       Date:  2017-06-26       Impact factor: 3.090

3.  Clinical characteristics and outcome of patients with enterococcal liver abscess.

Authors:  K Große; D Ohm; S Würstle; J F Brozat; R M Schmid; C Trautwein; A Stallmach; T Bruns; Philipp A Reuken
Journal:  Sci Rep       Date:  2021-11-15       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.